Alnylam Pharmaceuticals
ALNY
#1123
Rank
โ‚ฌ18.97 B
Marketcap
141,68ย โ‚ฌ
Share price
3.61%
Change (1 day)
-62.93%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company